Abstract:
Methods and kits for analysing a sample from a test subject. The methods involve determining the level of at least one compound selected from the group consisting of N- acetylglutamate, methionine, acetylcarnitine, indole-3 -acetate, 2-oxoglutarate, anserine, aspartate and butyrate in the sample from the test subject; and comparing the level of the at least one compound determined to at least one control level, wherein the levels of the at least one compound are indicative of whether the subject has hepatic cancer.
Abstract:
A system comprising a platform assembly comprising a master platform and a slave platform, both the master platform and the slave platform being moveable, the platform assembly further comprising a force feedback control arrangement for applying a force to the master platform in response to a force exerted on a slave device mounted on the platform.
Abstract:
The present invention relates to medicaments for the treatment of cystic fibrosis. Also provided are methods of preparing such medicaments so that they can be used in a treatment regime for cystic fibrosis. The present invention also provides a kit of parts including the medicament of the invention, as well as treatment regimes for cystic fibrosis.
Abstract:
The invention provides a process for the synthesis of a polycarbonate, the process comprising the step of reacting carbon dioxide with at least one epoxide in the presence of a catalyst of formula (I) and a chain transfer agent. The invention also provides a polymerisation system for the copolymerisation of carbon dioxide and at least one epoxide comprising a catalyst of formula (I) and a chain transfer agent, polycarbonates produced by the inventive process, a block copolymer comprising a polycarbonate produced by the inventive process and a method of producing the same. The invention also relates to novel catalysts of formula (III).
Abstract:
Disclosed herein is a method for diagnosing hepatic cancer by analysing a sample and determining the level of at least one compound selected from the group consisting of glycine, trimethylamine-N-oxide, hippurate and citrate and comparing the levels in the sample with control levels. The analysis of the sample can involve the determination of a profile for the sample. The methods disclosed are useful in distinguishing between a patient having hepatic cancer and a patient having cirrhosis.
Abstract:
The present invention relates to a layered fibrous construct for use as a scaffold for repairing or replacing cartilage or cartilage-like tissue, and a process for the production thereof.
Abstract:
Peptide analogues of PYY, compositions comprising said analogues and methods of using said analogues for the treatment and prevention of metabolic disorders, for example disorders of energy metabolism such as diabetes and obesity, and for a reduction in appetite, reduction in food intake or reduction of calorie intake in a subject.
Abstract:
The invention related to an in vitro population of cells comprising (i) a motor neuron comprising a transgene; said transgene encoding a photosensitive protein capable of triggering or suppressing an action potential upon illumination with light of cognate wavelength; and (ii) an astrocyte. The invention also provides an implantable device comprising a population of cells as described above, wherein said device is structured to retain the cell bodies within the device.
Abstract:
The present invention relates to multicomponent glasses and their use in powdered form as an additive in personal care products such as toothpastes.
Abstract:
A device comprising: two mutually immiscible conductive liquids arranged to form an interface therebetween; a plurality of nanoparticles localised at the said interface, the said nanoparticles each having a first region formed of a semiconductor having a first bandgap, the first region being surrounded by a second region having a second bandgap, the second bandgap being larger than the first bandgap; and means for applying an electric field to the said nanoparticles and thus, through the Stark effect, altering the optical absorption or emission characteristics of the nanoparticles.